Duncan-Williams Ups ISPH To Hold

by Lisa Levin, Benzinga Editor
February 18, 2011 6:44 AM | 9 seconds read |
Analysts at Duncan-Williams upgrade Inspire Pharmaceuticals Inc ISPH from “sell” to “hold.” ISPH shares gained 2.61% to close at $4.33 yesterday. More Analyst Ratings here
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: UpgradesAnalyst RatingsDuncan-WilliamsHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!